IN a recent issue of Nature, Jean Wang discussed the differences between the cellular and viral versions of the abl oncogene1. This week John Wyke reports some recent explorations of two versions of v-src and its cellular homologue.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wang, J.Y.J. Nature 304, (1983).
Waterfield, M.D. et al. Nature 304, 35 (1983).
Schwartz, D.E., Tizard, R. & Gilbert, W. Cell 32, 853 (1983).
Swanstrom, R., Parker, R., Varmus, H.E. & Bishop, J.M. Proc. natn. Acad. Sci. U.S.A. 80, 2519 (1983).
Takeya, T. & Hanafusa, H. Cell 32, 881 (1983).
Mardon, G. & Varmus, H. Cell 32, 871 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wyke, J. Evolution of oncogenes: From c-src to v-src. Nature 304, 491–492 (1983). https://doi.org/10.1038/304491a0
Issue Date:
DOI: https://doi.org/10.1038/304491a0
This article is cited by
-
Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks
Apoptosis (2016)
-
Onc genes and other new targets for cancer chemotherapy
Journal of Cancer Research and Clinical Oncology (1984)
